Recent price cuts by Chinese AI players, including Alibaba Cloud, are pushing LLM prices to historic lows. NewsLLM prices hit rock bottom in China as Alibaba Cloud enters the fray3 mins read
Skeptics say more government subsidies, skilled workers, and end customers are needed. InsightsCan investment from TSMC, Infineon, and others revive Europe’s chip dreams?7 mins read
Bringing you the latest updates on funding deals and activities in the Asia Pacific. NewsDeals in brief: Beppo secures pre-seed funding, Y Combinator invests in Phonely, xAI completes Series B round, and more4 mins read
Who knew the underperformance of a single model could spark such a profound change in the automaker’s strategy? InsightsLi Auto’s latest strategic shift leaves little margin for error6 mins read
Tencent is throwing its hat into the generative AI ring. InsightsTencent unveils AI upgrades to keep pace with tech rivals5 mins read
Luckin Coffee’s rapid expansion has positioned it as a dominant force in China’s coffee market, but at the cost of strained profit margins. NewsLuckin Coffee’s margins shrink amid expansion to outplay Starbucks4 mins read
Bringing you the latest updates on funding deals and activities in the Asia Pacific. NewsDeals in brief: Hitseries Capital backs Vietnam-based WeSale, LiveIn extends pre-Series B round, Zypp Electrics raises USD 15 million, and more3 mins read
Advances in CCUS technology are laying the groundwork for the mass sequestration of atmospheric carbon in China. NewsUpscaling CCUS efforts might be the next step in China’s green tech push3 mins read
Mitsui Fudosan is looking to spread the risk for the USD 5.8 billion Tsukiji market redevelopment. NewsWhy one of Japan’s biggest real estate projects is tapping Toyota3 mins read
Eli Lilly’s diabetes treatment Mounjaro and weight loss drug Zepbound both feature tirzepatide as their main ingredient. NewsChinese regulators greenlight Eli Lilly’s tirzepatide diabetes drug4 mins read
Most Recent